These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 28527096)

  • 1. Childhood Predictors of Young Adult Social Functioning in 22q11.2 Deletion Syndrome.
    Wagner KE; Kates WR; Fremont W; Antshel KM
    J Autism Dev Disord; 2017 Aug; 47(8):2480-2501. PubMed ID: 28527096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Premorbid adjustment and schizophrenia in individuals with 22q11.2 deletion syndrome.
    Yuen T; Chow EW; Silversides CK; Bassett AS
    Schizophr Res; 2013 Dec; 151(1-3):221-5. PubMed ID: 24262682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 22q11.2 duplication syndrome: elevated rate of autism spectrum disorder and need for medical screening.
    Wenger TL; Miller JS; DePolo LM; de Marchena AB; Clements CC; Emanuel BS; Zackai EH; McDonald-McGinn DM; Schultz RT
    Mol Autism; 2016; 7():27. PubMed ID: 27158440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neurocognitive and psychiatric management of the 22q11.2 deletion syndrome].
    Demily C; Rossi M; Schneider M; Edery P; Leleu A; d'Amato T; Franck N; Eliez S
    Encephale; 2015 Jun; 41(3):266-73. PubMed ID: 25523123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Education and employment trajectories from childhood to adulthood in individuals with 22q11.2 deletion syndrome.
    Mosheva M; Pouillard V; Fishman Y; Dubourg L; Sofrin-Frumer D; Serur Y; Weizman A; Eliez S; Gothelf D; Schneider M
    Eur Child Adolesc Psychiatry; 2019 Jan; 28(1):31-42. PubMed ID: 29934817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin D deficiency, behavioral atypicality, anxiety and depression in children with chromosome 22q11.2 deletion syndrome.
    Kelley L; Sanders AF; Beaton EA
    J Dev Orig Health Dis; 2016 Dec; 7(6):616-625. PubMed ID: 27827293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attention Deficit Hyperactivity Disorder Symptoms and Psychosis in 22q11.2 Deletion Syndrome.
    Niarchou M; Calkins ME; Moore TM; Tang SX; McDonald-McGinn DM; Zackai EH; Emanuel BS; Gur RC; Gur RE
    Schizophr Bull; 2018 Jun; 44(4):824-833. PubMed ID: 29040797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The social brain network in 22q11.2 deletion syndrome: a diffusion tensor imaging study.
    Olszewski AK; Kikinis Z; Gonzalez CS; Coman IL; Makris N; Gong X; Rathi Y; Zhu A; Antshel KM; Fremont W; Kubicki MR; Bouix S; Shenton ME; Kates WR
    Behav Brain Funct; 2017 Feb; 13(1):4. PubMed ID: 28209179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Childhood Executive Functioning Predicts Young Adult Outcomes in 22q11.2 Deletion Syndrome.
    Albert AB; Abu-Ramadan T; Kates WR; Fremont W; Antshel KM
    J Int Neuropsychol Soc; 2018 Oct; 24(9):905-916. PubMed ID: 30375321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predominant negative symptoms in 22q11.2 deletion syndrome and their associations with cognitive functioning and functional outcome.
    Schneider M; Van der Linden M; Menghetti S; Glaser B; Debbané M; Eliez S
    J Psychiatr Res; 2014 Jan; 48(1):86-93. PubMed ID: 24189154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The dimensional structure of psychopathology in 22q11.2 Deletion Syndrome.
    Niarchou M; Moore TM; Tang SX; Calkins ME; McDonald-McGuinn DM; Zackai EH; Emanuel BS; Gur RC; Gur RE
    J Psychiatr Res; 2017 Sep; 92():124-131. PubMed ID: 28433949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subthreshold social cognitive deficits may be a key to distinguish 22q11.2DS from schizophrenia.
    Peyroux E; Rigard C; Saucourt G; Poisson A; Plasse J; Franck N; Demily C
    Early Interv Psychiatry; 2019 Apr; 13(2):304-307. PubMed ID: 29575660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors and the evolution of psychosis in 22q11.2 deletion syndrome: a longitudinal 2-site study.
    Gothelf D; Schneider M; Green T; Debbané M; Frisch A; Glaser B; Zilkha H; Schaer M; Weizman A; Eliez S
    J Am Acad Child Adolesc Psychiatry; 2013 Nov; 52(11):1192-1203.e3. PubMed ID: 24157393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developmental trajectories of brain structure in adolescents with 22q11.2 deletion syndrome: a longitudinal study.
    Gothelf D; Penniman L; Gu E; Eliez S; Reiss AL
    Schizophr Res; 2007 Nov; 96(1-3):72-81. PubMed ID: 17804201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multitasking Abilities in Adolescents With 22q11.2 Deletion Syndrome: Results From an Experimental Ecological Paradigm.
    Schneider M; Eliez S; Birr J; Menghetti S; Debbané M; Van der Linden M
    Am J Intellect Dev Disabil; 2016 Mar; 121(2):151-64. PubMed ID: 26914469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Social cognition and real-life functioning in patient samples with 22q11.2 deletion syndrome with or without psychosis, compared to a large sample of patients with schizophrenia only and healthy controls.
    Frascarelli M; Accinni T; Buzzanca A; Carlone L; Ghezzi F; Moschillo A; Kotzalidis GD; Bucci P; Giordano GM; Fanella M; Di Bonaventura C; Putotto C; Marino B; Pasquini M; Biondi M; Di Fabio F
    J Neuropsychol; 2023 Sep; 17(3):564-583. PubMed ID: 37159847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive behavioral therapy in 22q11.2 microdeletion with psychotic symptoms: What do we learn from schizophrenia?
    Demily C; Franck N
    Eur J Med Genet; 2016 Nov; 59(11):596-603. PubMed ID: 27639442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on the 22q11.2 deletion syndrome and its relevance to schizophrenia.
    Van L; Boot E; Bassett AS
    Curr Opin Psychiatry; 2017 May; 30(3):191-196. PubMed ID: 28230630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 22q11.2DS deletion syndrome: developmental milestones in infants and toddlers.
    Roizen NJ; Antshel KM; Fremont W; AbdulSabur N; Higgins AM; Shprintzen RJ; Kates WR
    J Dev Behav Pediatr; 2007 Apr; 28(2):119-24. PubMed ID: 17435462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of 22q11.2 Deletion Syndrome via Newborn Screening for Severe Combined Immunodeficiency.
    Barry JC; Crowley TB; Jyonouchi S; Heimall J; Zackai EH; Sullivan KE; McDonald-McGinn DM
    J Clin Immunol; 2017 Jul; 37(5):476-485. PubMed ID: 28540525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.